copper metabolism

Jerusalem, Israel, September 8, 2026 Scinai Immunotherapeutics has announced a strategic refocusing of its research and development portfolio following...

Chicago, Illinois, USA, September 8, 2026 Orphalan has initiated the global Phase 3 TRADITiONAL clinical trial evaluating an investigational...

WILMETTE, Ill., June 26, 2026 Monopar Therapeutics announced new analyses from its Phase 3 FoCus clinical trial demonstrating that...

Wilmette, Illinois, USA, April 19, 2026 In a significant advancement for rare disease therapeutics, Monopar Therapeutics Inc. has presented...